Benralizumab is effective in reducing asthma exacerbations: Results from the ZEPHYR 2 study

被引：0
|
作者：
Maselli, Diego J.
Carstens, Donna
Yang, Danni
Mu, Fan
Young, Joshua
Cook, Erin E.
Betts, Keith A.
Chung, Yen
机构：
来源：
ALLERGY AND ASTHMA PROCEEDINGS | 2022年 / 43卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [31] Benralizumab Reduces Exacerbations and Improves Lung Function in Patients From Republic of Korea With Severe, Uncontrolled Asthma: Subgroup Analysis of the SIROCCO Trial
    Park, Hae-Sim
    Lee, Sang Haak
    Werkstrom, Viktoria
    Wu, Yanping
    Zangrilli, James
    Gopalan, Gokul
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB14 - AB14
  • [32] A Phase 2a Study Of Benralizumab For Patients With Eosinophilic Asthma In South Korea And Japan
    Adachi, M.
    Kim, M. -K.
    Imai, N.
    Nakanishi, T.
    Ohta, K.
    Tohda, Y.
    Park, H. -S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [33] Prediction of Asthma Exacerbations in Elderly Adults: Results of a 1-Year Prospective Study
    Park, Heung-Woo
    Kim, Tae-Wan
    Song, Woo-Jung
    Kim, Sae-Hoon
    Park, Hye-Kyung
    Kim, Sang-Heon
    Kwon, Yong Eun
    Kim, Tae-Bum
    Lee, Byung-Jae
    Jee, Young-Koo
    Choi, Byoung Whui
    Cho, Sang-Heon
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (09) : 1631 - 1632
  • [34] Prediction of Asthma Exacerbations in Children by Innovative Exhaled Inflammatory Markers: Results of a Longitudinal Study
    van Vliet, Dillys
    Alonso, Ariel
    Rijkers, Ger
    Heynens, Jan
    Rosias, Philippe
    Muris, Jean
    Jobsis, Quirijn
    Dompeling, Edward
    PLOS ONE, 2015, 10 (03):
  • [35] HEALTHCARE RESOURCE UTILIZATION OF SEVERE EOSINOPHILIC ASTHMA PATIENTS TREATED WITH BENRALIZUMAB IN REAL-LIFE: RESULTS FROM THE PORTUGUESE BETREAT STUDY
    Chaves-Loureiro, C.
    Carrico, F.
    Brito, U.
    Belchior, I
    Fernandes, R. A.
    Sousa, N.
    Mendes, A.
    Loureiro, C.
    Pardal, C.
    Ribeiro, L.
    Reis, G.
    Pires, N.
    Teles, C.
    Placido, J.
    Boaventura, R.
    Lima, R.
    Pardal, M.
    Marques, A.
    Martinho, H.
    Bernardo, F.
    VALUE IN HEALTH, 2023, 26 (12) : S302 - S302
  • [36] Seasonal Variability of Exacerbations in Patients with Severe, Uncontrolled Asthma and Clinical Benefits of Tezepelumab: Results from the PATHWAY Phase 2b Study
    Corren, J.
    Karpefors, M.
    Hellqvist, A.
    Parnes, J. R.
    Colice, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [37] Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
    Corren, J.
    Karpefors, M.
    Hellqvist, A.
    Parnes, J. R.
    ALLERGY, 2020, 75 : 17 - 18
  • [38] Exacerbations of Mild Asthma Are Common: Results From a Large Community-Based Sample
    Teague, W. Gerald
    Griffiths, Cameron D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (10): : 2717 - 2718
  • [39] Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma
    Wisnivesky, Juan
    Federmann, Emily
    Eckert, Laurent
    West, Erin
    Amand, Caroline
    Kamar, Driss
    Teper, Ariel
    Khan, Asif H.
    JOURNAL OF ASTHMA, 2023, 60 (06) : 1072 - 1079
  • [40] Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study
    Kupczyk, Maciej
    Haque, Shushila
    Sterk, Peter J.
    Nizankowska-Mogilnicka, Ewa
    Papi, Alberto
    Bel, Elisabeth H.
    Chanez, Pascal
    Dahlen, Barbro
    Gaga, Mina
    Gjomarkaj, Mark
    Howarth, Peter H.
    Johnston, Sebastian L.
    Joos, Guy F.
    Kanniess, Frank
    Tzortzaki, Eleni
    James, Anna
    Middelveld, Roelinde J. M.
    Dahlen, Sven-Erik
    THORAX, 2013, 68 (07) : 611 - 618
12345